101 - 125 of 35.006
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Münchener Rück Call 580,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 13,30x
- Analysis
- Novo Nordisk Call 270,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 4,73x
- Analysis
- Münchener Rück Call 620,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 18,91x
- Analysis
- Waste Management Inc Call 270,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 23,03x
- Analysis
- Intuitive Surgical Call 450,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,96x
- Analysis
- Bayer Call 24,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 5,56x
- Analysis
- Weibo Corp Call 9,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 4,53x
- Analysis
- Abbvie Inc Call 190,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 9,84x
- Analysis
- Siemens Call 210,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,62x
- Analysis
- Novo Nordisk Call 530,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,11x
- Analysis
- Amazon.com Call 265,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 10,02x
- Analysis
- Novo Nordisk Call 510,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 6,87x
- Analysis
- FCT IM Call 16,40 19 Sept 2025
- Goldman Sachs
- 19.09.25
- 7,82x
- Analysis
- Zalando SE Call 22,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 5,26x
- Analysis
- Union Pacific Corp Call 225,00 19 Sept 2025
- Goldman Sachs
- 19.09.25
- 22,30x
- Analysis
- Novo Nordisk Call 255,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 3,48x
- Analysis
- Novo Nordisk Call 275,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 3,94x
- Analysis
- Novo Nordisk Call 275,00 19 Sept 2025
- Goldman Sachs
- 19.09.25
- 5,53x
- Analysis
- Novo Nordisk Call 530,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 6,74x
- Analysis
- Swiss Life Holding Call 880,00 19 Sept 2025
- Goldman Sachs
- 19.09.25
- 16,82x
- Analysis
- Novo Nordisk Call 275,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,29x
- Analysis
- Novo Nordisk Call 345,00 19 Sept 2025
- Goldman Sachs
- 19.09.25
- 10,13x
- Analysis
- Fresenius Medical Care Call 42,00 19 Sept 2025
- Goldman Sachs
- 19.09.25
- 12,73x
- Analysis
- Novo Nordisk Call 355,00 19 Sept 2025
- Goldman Sachs
- 19.09.25
- 10,54x
- Analysis
- Accenture Call 240,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,78x
- Analysis